Relapsed leukemia
Clinical trials for Relapsed leukemia explained in plain language.
Never miss a new study
Get alerted when new Relapsed leukemia trials appear
Sign up with your email to follow new studies for Relapsed leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new drug duo outsmart a tough childhood leukemia?
Disease control Recruiting nowThis early-stage trial is testing whether combining two targeted drugs—olverembatinib and APG-2575—can safely and effectively treat children with a specific type of acute lymphoblastic leukemia (Ph+ ALL) that has relapsed or not responded to standard treatments. The study will fi…
Matched conditions: RELAPSED LEUKEMIA
Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New Three-Drug cocktail aims to outsmart tough leukemia
Disease control Recruiting nowThis study tests a new combination of three drugs—roginolisib, venetoclax, and rituximab—in people with chronic lymphocytic leukemia (CLL) that has come back or not responded to prior treatments. The goal is to see if the combination is safe and can wipe out leukemia cells more e…
Matched conditions: RELAPSED LEUKEMIA
Phase 1/2 • Sponsor: Jennifer R. Brown, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Experimental combo aims to help leukemia patients reach transplant
Disease control Recruiting nowThis early-phase study tests whether giving chemotherapy followed by an infusion of immune cells from a partially matched donor can help patients with relapsed or refractory leukemia get to a stem cell transplant. Only 5 participants will be enrolled to check safety and side effe…
Matched conditions: RELAPSED LEUKEMIA
Phase 1 • Sponsor: Beijing 302 Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC